Table 1 Patient characteristics.

From: Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy

Diagnosis

n

Sex female (%)

Age median (range)

Autoantibody

Therapy

Dose

RA

15

12 (80.0)

53 (34–68)

anti-CCP

RTX

repeated 1000 mg

PV

10

7 (70.0)

56 (31–71)

anti-Dsg3

RTX

repeated 1000 mg

AAV

11

4 (36.4)

53 (21–77)

anti-PR3

RTX

repeated 1000 mg

MS

15

6 (40.0)

57 (46–62)

-

OCR

2 × 300 mg

2 × 600 mg